ISRCTN57142415进行中（未招募）未知
Intervention to preserve vision in idiopathic intracranial hypertension: evaluation of clinical effectiveness and cost-effectiveness
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •List of principal criteria:
- •1. Diagnosis of idiopathic intracranial hypertension (IIH) by the IIH consensus guideline with bilateral papilloedema and a risk of permanent visual loss
- •2. Visual loss in at least one eye (study eye), secondary to papilloedema that cannot be explained by other ocular or central nervous system (CNS) pathology
- •3. Participants will be suitable for both cerebrospinal fluid (CSF) shunting and dural venous sinus stenting (DVSS)
- •4. Age 18 to <64 years at the time of consent
- •5. Able to provide written informed consent
排除标准
- •List of principal criteria:
- •1. Presence of current venous sinus thrombosis on diagnostic brain imaging by either Magnetic Resonance Imaging (MRI), Magnetic Resonance Venography (MRV) or Computed Tomography Venography (CTV)
- •2. A completely normal CTV (or MRV) with clear visualisation of the whole sinus with no evidence of stenosis(es)
- •3. Previous surgery for IIH including, optic nerve sheath fenestration, CSF shunting procedures, sub-temporal decompression and DVSS.
- •4. Previous bariatric surgery within the last 3 months
- •5. Patients with a past ophthalmic history affecting the eligible eye(s) that could affect the vision (e.g. prior optic atrophy)
- •6. History of any clinically significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject’s ability to participate in the study
- •7. Have participated in any other interventional study within 1 month prior to the screening visit (of note participation in the IIH Life database or other observational studies will not prevent enrolment in this study)
- •8. Previous randomisation for treatment in the present study
- •9. Pregnant
- •10. Absolute or serious contraindication to standard anti-thrombotic regimen peri- and post-stenting
- •11. Other secondary causes of raised intracranial pressure, including: haematological (e.g. moderate to severe anaemia); causes of venous obstruction (e.g. cerebral venous sinus thrombosis); medications (e.g. quinolones); systemic disorders (e.g. chronic kidney disease); endocrine (e.g. Addison’s disease); and syndromic (See Protocol Appendix 3 for a full list)
- •12. Absolute or serious contraindication for general anaesthesia
研究者
相似试验
进行中（未招募）
不适用
Prevention of vision loss in patients with age-related neovascular macular degeneration by intravitreal injection of bevacizumab and ranibizumab in a typical outpatient setting - VIBERAEUCTR2007-004721-23-DEKlinikum Bremen-Mitte gGmbH
已完成
不适用
The treatment of retinopathy of prematurity with AvastiRetinopathy of prematurity.Retinopathy of prematurityIRCT2014101618966N2o sponsor40
已完成
不适用
Physical therapy for visually impaired peopleVisually Impaired PersonsQuality of LifeI01.800H53-H54RBR-2ssg4wniversidade Federal do Triângulo Mineiro
Unknown
3 期
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and RanibizumabAge-Related Neovascular Macular DegenerationNCT00559715Klinikum Bremen-Mitte, gGmbH366
进行中（未招募）
不适用
Retinal organoids for the study of inherited retinal diseasesInherited retinal degenerationsEye DiseasesISRCTN12295348niversity of Oxford60